These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells. Zamboni M; Civitareale D Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701 [TBL] [Abstract][Full Text] [Related]
9. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas. Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788 [TBL] [Abstract][Full Text] [Related]
10. Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer. Clarke N; Biscocho J; Kwei KA; Davidson JM; Sridhar S; Gong X; Pollack JR PLoS One; 2015; 10(11):e0142061. PubMed ID: 26556242 [TBL] [Abstract][Full Text] [Related]
11. Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss. Karthikeyan SK; Gimbrone NT; Percy TR; Cress WD Cancer Treat Res Commun; 2021; 26():100286. PubMed ID: 33338855 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene. Cao Y; Vo T; Millien G; Tagne JB; Kotton D; Mason RJ; Williams MC; Ramirez MI J Biol Chem; 2010 Jan; 285(3):2152-64. PubMed ID: 19906647 [TBL] [Abstract][Full Text] [Related]
13. Fan TWM; Bruntz RC; Yang Y; Song H; Chernyavskaya Y; Deng P; Zhang Y; Shah PP; Beverly LJ; Qi Z; Mahan AL; Higashi RM; Dang CV; Lane AN J Biol Chem; 2019 Sep; 294(36):13464-13477. PubMed ID: 31337706 [TBL] [Abstract][Full Text] [Related]
15. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1). Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of the serine and glycine pathway in cancer cells. Antonov A; Agostini M; Morello M; Minieri M; Melino G; Amelio I Oncotarget; 2014 Nov; 5(22):11004-13. PubMed ID: 25436979 [TBL] [Abstract][Full Text] [Related]
17. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308 [TBL] [Abstract][Full Text] [Related]
18. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371 [TBL] [Abstract][Full Text] [Related]
19. Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice. Haji N; Riebe I; Aguilar-Valles A; Artinian J; Laplante I; Lacaille JC Mol Autism; 2020 May; 11(1):29. PubMed ID: 32375878 [TBL] [Abstract][Full Text] [Related]
20. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells. D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]